- Industry
- 1 min read
Australia's Estia Health opens books to Bain Capital for improved offer
Late in March, Estia received a non-binding buyout proposal from the US private investment firm for A$775.1 million ($523.11 million). The proposal implies a value of A$3.00 per share, which was at a 28.2 per cent premium to Estia's close at the time of receiving the offer.
Late in March, Estia received a non-binding buyout proposal from the US private investment firm for A$775.1 million ($523.11 million). The proposal implies a value of A$3.00 per share, which was at a 28.2 per cent premium to Estia's close at the time of receiving the offer.
"The board does not regard the indicative proposal as compelling having regard to price and conditionality," Estia said in a statement.
The Sydney-based company said it plans to hold back on acquiring shares under its recent on-market share buyback program keeping in mind its engagement with Bain, which is preliminary in nature.
COMMENTS
All Comments
By commenting, you agree to the Prohibited Content Policy
PostBy commenting, you agree to the Prohibited Content Policy
PostFind this Comment Offensive?
Choose your reason below and click on the submit button. This will alert our moderators to take actions